Difference between NASH and NAFLD

Reading File

Searching the Web

NAFLD vs NASH difference spectrum 2024 2025

Finding Sources

Searching PubMed

"NAFLD" AND "NASH" AND "MASLD" nomenclature

Reading File

Here is a thorough breakdown of the difference between NAFLD and NASH:

NAFLD vs NASH

The Relationship: Spectrum, Not Two Separate Diseases

NAFLD is the overarching term for the full spectrum of non-alcoholic liver disease. NASH is a specific, more advanced stage within that spectrum. Think of it as:

NAFLD (umbrella) → Simple Steatosis (benign) → NASH (active injury) → Fibrosis → Cirrhosis → HCC

Side-by-Side Comparison

Feature	NAFLD (Simple Steatosis)	NASH
Definition	Fat accumulation (>5% of hepatocytes) with no significant alcohol use	Fat + inflammation + hepatocyte injury (ballooning)
Histology	Steatosis only	Steatosis + lobular inflammation + hepatocellular ballooning (± fibrosis)
Liver injury markers	Usually normal or mildly elevated transaminases	Elevated ALT/AST (AST:ALT ratio typically <1)
Symptoms	Typically asymptomatic	Often asymptomatic, but may have fatigue, malaise, RUQ discomfort
Fibrosis risk	Very low progression risk	Can progress to fibrosis, cirrhosis, and HCC
Diagnosis	Imaging (ultrasound, MRI) or incidental lab finding	Requires liver biopsy for definitive diagnosis
Prognosis	Generally benign; may regress	Potentially serious; can lead to end-stage liver disease

Pathogenesis: Why NASH is Worse

Both conditions begin with insulin resistance and obesity, which drive excess free fatty acid uptake into hepatocytes. In NASH, additional hits cause overt liver injury:

Inflammasome activation in hepatocytes - releases pro-inflammatory cytokine IL-1
Increased reactive oxygen species (ROS) production
ER stress and mitochondrial dysfunction
Lipotoxicity from specific lipid metabolites
Gut microbiome dysbiosis - increased gut-derived endotoxins drive hepatic inflammation
Hepatocyte injury then activates stellate cells, leading to collagen deposition and fibrosis

(Robbins & Kumar Basic Pathology)

Risk Factors (shared by both)

Type 2 diabetes / family history
Obesity (especially central/visceral)
Dyslipidemia (high triglycerides, low HDL, high LDL)
Hypertension / metabolic syndrome

Diagnosis: The Key Practical Difference

NAFLD can be diagnosed with imaging (hepatic steatosis on ultrasound/MRI) + exclusion of alcohol and other causes.
NASH requires a liver biopsy to confirm the combination of steatosis, lobular inflammation, and hepatocyte ballooning. No blood test or imaging alone can reliably distinguish simple steatosis from NASH.

Important Naming Update (2023 onward)

The hepatology community has recently updated the terminology:

NAFLD is being replaced by MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease)
NASH is being replaced by MASH (Metabolic dysfunction-Associated SteatoHepatitis)

The new names better reflect the underlying metabolic drivers and remove the stigmatizing "non-alcoholic" label. As of 2024-2025, MASLD/MASH is the preferred terminology in major guidelines, though NAFLD/NASH remains widely used in clinical practice.

Clinical Significance

NAFLD (simple steatosis) carries a low but non-zero risk of progression - roughly 10-20% of patients progress to NASH over time.
NASH is a leading and growing indication for liver transplantation in the US, and is set to overtake HCV as the primary driver of hepatocellular carcinoma.
Patients with NAFLD also have an increased risk of coronary artery disease due to shared metabolic risk factors.
Treatment for both: weight reduction, exercise, diet, and reversal of insulin resistance. Bariatric surgery is an option in selected cases. Drug therapies specifically targeting MASH (e.g., resmetirom/Rezdiffra) have received FDA approval.

Give you give me the difference of the two table you have above in a image form so that I can download that

Reading File

Generating Image

Here's your comparison table as an image:

You can right-click the image and select "Save image as..." to download it directly to your device.

Give me the spectrum of disease

Generating Image

Here's the full disease spectrum. Key points to note:

The 6 stages:

Normal Liver - baseline, no fat accumulation
Simple Steatosis (NAFLD/MASLD) - fat only, no injury, largely reversible
NASH/MASH - fat + inflammation + hepatocyte ballooning; the critical inflection point
Advanced Fibrosis (F3) - bridging fibrosis, rising portal hypertension risk
Cirrhosis (F4) - structural liver remodeling, nodular architecture
End-Stage / HCC - liver failure or hepatocellular carcinoma, transplant territory

Important nuances:

Only about 10-20% of people with simple steatosis progress to NASH
Progression is not always linear - some patients develop HCC even without full cirrhosis in NASH
Stages 1-3 are potentially reversible with weight loss (even 7-10% body weight loss significantly reduces liver fat and inflammation)
The entire spectrum is driven by the same metabolic substrate: insulin resistance, obesity, and dyslipidemia

Right-click the image to save it.

This is a shared conversation. Sign in to Orris to start your own chat.